These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 13759106)
21. Sarcoma 180 inhibition by combinations of 6-thioguanine and uracil mustard. BOOTH BA; SARTORELLI AC Science; 1962 Oct; 138(3539):518-9. PubMed ID: 14013827 [TBL] [Abstract][Full Text] [Related]
22. [Results of dopan therapy of lymphogranulomatosis based on the data of the Khirgizin Scientific Research Institute of Oncology and Radiology]. Sikorskaia IaV Sov Zdravookhr Kirg; 1965; 2():34-8. PubMed ID: 4221039 [No Abstract] [Full Text] [Related]
23. [Reduction of carcinostatic action of dopan by its structural analogues]. PLATONOVA GN Patol Fiziol Eksp Ter; 1957; 1(3):22-8. PubMed ID: 13484272 [No Abstract] [Full Text] [Related]
24. [The use of embichin and dopan in ophthalmology]. BEREZINSKAIA DI; PLOTNIKOVA TN Vestn Oftalmol; 1961; 74():63-6. PubMed ID: 13867540 [No Abstract] [Full Text] [Related]
25. [Result of use of dopan in treatment of chronic myeloleukosis]. MOKEEVA RA Sov Med; 1958 Sep; 22(9):42-6. PubMed ID: 13615483 [No Abstract] [Full Text] [Related]
26. [Effect of serotonin on the antineoplastic activity and toxicity of sarcolysin and dopan]. Mal'tseva LF Farmakol Toksikol; 1966; 29(6):698-701. PubMed ID: 6000367 [No Abstract] [Full Text] [Related]
28. A clinical study of 5-fluorouracil. GOLD GL; HALL TC; SHNIDER BJ; SELAWRY O; COLSKY J; OWENS AH; DEDERICK MM; HOLLAND JF; BRINDLEY CO; JONES R Cancer Res; 1959 Oct; 19():935-9. PubMed ID: 13850554 [No Abstract] [Full Text] [Related]
29. A synopsis of recent investigations of 6-azauridine (NSC-32074). WELCH AD; HANDSCHUMACHER RE; FINCH SC; JAFFE JJ; CARDOSO SS; CALABRESI P Cancer Chemother Rep; 1960 Nov; 9():39-46. PubMed ID: 13784172 [No Abstract] [Full Text] [Related]
30. [Research on the antimitotic properties of antagonists of natural pyrimidine bases. I. 5-Fluorouracil and related compounds]. DEYSSON G; TRUHAUT R Bull Soc Chim Biol (Paris); 1962; 44():513-24. PubMed ID: 13885944 [No Abstract] [Full Text] [Related]
31. Potentiation of 5-fluorouracil by combination chemotherapy in animals. WOLBERG WH; CURRERI AR Cancer Chemother Rep; 1960 Feb; 6():6-7. PubMed ID: 13845611 [No Abstract] [Full Text] [Related]
32. [Research on the possibilities of inducing antigenic changes in tumor cells by treatment "in vivo" with chemotherapeutic agents]. Melan F; Nicolin A; Testorelli C Arch Ital Patol Clin Tumori; 1968; 11(1):203-13. PubMed ID: 5745128 [No Abstract] [Full Text] [Related]
33. Toxicity of dopan, chlorambucil and endoxan by reduced serotonin. Man'ko YK Fed Proc Transl Suppl; 1966; 25(6):1073-5. PubMed ID: 5225271 [No Abstract] [Full Text] [Related]
34. Biochemical changes during treatment with 5-fluorouracil. REICHARD P Cancer Chemother Rep; 1962 Feb; 16():347-52. PubMed ID: 14491142 [No Abstract] [Full Text] [Related]
35. Intracellular distribution of 5-bis(2-chloroethyl) aminouracil-2-C-14 in tissues of tumor-bearing rats. BYVOET P; BUSCH H Cancer Res; 1962 Feb; 22():249-53. PubMed ID: 13875353 [No Abstract] [Full Text] [Related]
36. Activity of combinations of uracil mustard (NSC-34462) and 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone) [KTS; NSC-82116] against murine tumors. Petering HG; Buskirk HH; Crim JA Cancer Chemother Rep; 1966 Nov; 50(8):557-64. PubMed ID: 5978728 [No Abstract] [Full Text] [Related]
38. New cancerostatics developed in Czechoslovakia. Introductory lecture. Semonský M Neoplasma; 1971; 18(5):431-4. PubMed ID: 5171223 [No Abstract] [Full Text] [Related]
39. [Experimental study of antitumor action of rubomycin in combination with some cytostatic compounds]. Rossolimo OK; Lepeshkina GN Antibiotiki; 1967 Mar; 12(3):206-12. PubMed ID: 4969789 [No Abstract] [Full Text] [Related]